Recent studies suggested that long noncoding RNAs (lncRNAs) were widely transcribed in the genome, but their potential roles in the genetic complexity of human disorders required further exploration. The purpose of the present study was to explore genetic polymorphisms of lncRNAs associated with bone mineral density (BMD) and its potential value. Based on the lncRNASNP database, 55,906 lncSNPs were selected to conduct a genome-wide association study meta-analysis among 11,140 individuals of seven independent studies for BMDs at femoral neck (FN), lumbar spine, and total hip (HIP). Promising results were replicated in Genetic Factors for Osteoporosis Consortium (GEFOS Sequencing, n = 32,965).
INTRODUCTION
Osteoporosis is a prevalent skeletal disorder characterized by excessive bone loss and skeletal fragility thus greatly increased risk of fractures (Liu, Zhang, Papasian, & Deng, 2014; Zheng et al., 2015) . Bone mineral density (BMD) as the major predictor of osteoporotic fractures is highly heritable. Recently, large-scale meta-analysis of genome-wide association studies (GWAS) have identified a great quantity of genetic variants, both common and rare, as well as microRNA variants, associated with BMD and osteoporosis related traits (Lei, Papasian, & Deng, 2011; Liu et al., 2014; Styrkarsdottir et al., 2013; Zheng et al., 2015) .
Long noncoding RNAs (lncRNAs), which were previously thought to be genome "transcriptional noise," have come to gain attention for their significant functional and structural roles and have been proposed to be key regulators of chromatin reconstitution, transcriptional regulation, posttranscriptional processing, and of protein metabolism (Mercer, Dinger, & Mattick, 2009; Ponting et al., 2009) . LncRNAs, which are defined as noncoding RNA (ncRNA) transcripts longer than 200 nucleotides, can be divided into five broad categories: sense, antisense, bidirectional, intronic, and intergenic (Mattick & Rinn, 2015) . They are involved in diverse biological process and pathogenesis of disorders, such as osteoblast differentiation (Zhu & Xu, 2013; Zhuang et al., 2015) , osteosarcoma (Cong, Li, Jing, & Li, 2016) , and cardiovascular diseases (Klattenhoff et al., 2013) . Recent studies have proved that lncRNAs can physically interact with other genes to regulate their expressions. For example, the lncRNA-ANCR (antidifferentiation ncRNA) catalyzed Runx2 H3K27me3 to suppress Runx2 expression and osteoblast differentiation (Zhu & Xu, 2013) ; upregulation of lncRNA maternally expressed gene 3 facilitated osteogenic differentiation of mesenchymal stem cells by targeting BMP4 transcription (Zhuang et al., 2015) .
GWAS found that a greater than anticipated part of the identified variants were not located in the coding region, rather mapped to noncoding regions (Hindorff et al., 2009; Jin et al., 2011) . Recently, accumulating evidence has suggested an influential role of genetic polymorphisms of lncRNAs with diseases' occurrence and progress, mostly in cancer and carcinogenesis (Jin et al., 2011) . Jin et al. (2011) performed a meta-analysis using the 1000 Genomes data and found that prostate cancer susceptibility loci were abundant in lncRNAs. A recent study detected the association of lncRNA polymorphisms with lung cancer and found that genetic variants in lncRNAs HOTTIP, HOTAIR, CCAT2, ANRIL, and MALATI were significantly associated with lung cancer susceptibility or chemotherapy response (Gong et al., 2016) . A case-control study of breast cancer in a Chinese population identified three polymorphisms in the lncRNA HOTAIR associated with breast cancer (Yan et al., 2015) . However, to date, there is no specific research about the association between lncRNA's polymorphisms and osteoporosis risk.
To explore osteoporosis susceptibility loci at lncRNAs, we performed a meta-analysis of multiple GWASs with diverse ancestries for polymorphisms of lncRNAs and BMD.
Furthermore, we analyzed the potential effects on lncRNA structure and function of interested single nucleotide polymorphisms (SNPs).
MATERIALS AND METHODS

Study samples
Discovery sample: Our study consisted of 11,140 individuals from seven GWASs, three of which were "in-house" studies: (1) Omaha Osteoporosis Study (OOS; N = 987, Caucasian ancestry), (2) Kansas-City Osteoporosis Study (KCOS; N = 2250, Caucasian ancestry), and (3) China Osteoporosis Study (COS; N = 1547, Han Chinese ancestry); the other four were "external" studies, downloaded from Genotypes and Phenotypes (dbGaP) ( https://www.ncbi.nlm.nih.gov/gap/): (1) Framingham Heart Study (FHS; N = 3747, Caucasian ancestry), (2) Indiana Fragility Study (IFS; N = 1488, Caucasian ancestry), (3) Women's Health Initiative (WHI) Observational Study African-American Sub-study (WHI-AA; N = 712, African ancestry), and (4) WHI Observational Study Hispanic Sub-study (WHI-HIS; N = 409, Hispanic ancestry).
BMD (g/cm 2 ) at lumbar spine (L1-L4) and hip, including femoral neck, trochanter, and intertrochanter, were measured using dual-energy x-ray absorptiometry scanners (either Lunar Corp., Madison, WI, or Hologic Inc., Bedford, MA), and details of bone densitometer of each sample are given in Table 1 . The total hip BMD was a combined value at the three measured regions (Tan et al., 2015) . The densitometer was calibrated daily, and long-term precision was monitored with the control vertebral phantom (Tan et al., 2015 coefficient of variation of measured BMD values was 1.01% and 1.34% at the spine total hip (Tan et al., 2015) . Hologic BMD was converted to Lunar BMD using published equations derived from women for lumbar spine and femoral neck (Genant et al., 1995; Lu, Fuerst, Hui, & Genant, 2001; Shepherd et al., 2002) . Conversion equations in men for Hologic to Lunar BMD were derived using Deming regression analysis (Ganda, Nguyen, & Pocock, 2014) . BMD was calculated separately using Hologic and Lunar BMD at the lumbar spine, femoral neck, and total hip. All samples were approved by the Institutional Review Board or Research Administration of the institutions involved. Signed informed consent documents were obtained from all study participants before entering the study. Detailed samples information was described previously .
Replication sample: The replication dataset was the metaanalysis from the Genetic Factors for Osteoporosis Consortium (GEFOS Sequencing), the largest meta-analysis to date in the bone field, including 32,965 individuals of Caucasians descent with the study detailed in a recent publication (Zheng et al., 2015) . Each SNP and its association to femoral neck and lumbar spine BMD in the meta-analysis were downloaded from http://www.gefos.org/. FHS, IFS and WHI samples in the GEFOS Sequencing dataset were overlapped with the samples in the discovery dataset. Since the GEFOS dataset only provides the summary statistic data of all samples, we cannot exclude the four dbGAP samples from the replication sample.
Genotyping and imputation
Each GWAS sample was genotyped by high-throughput SNP genotyping array. Genotyping quality control criteria were used as follows: individual missing data < 5%, SNP call rate > 95%, and Hardy-Weinberg equilibrium Pvalue > 1.00 × 10 −5 . Genotypes of each individual study sample were imputed by the relevant reference panel in the 1000 Genome Project. SNPs (at the very least one sample) and minor allele frequency (MAF) > 0.05 (at the very least one sample) were included in the association analysis. For detailed genotyping method, please refer to previous study .
LncRNA SNP selection
LncRNA data were downloaded from the LncRNASNPhuman database (http://bioinfo.life.hust.edu.cn/lncRNA SNP), obtained from dbSNP of NCBI and LNCipedia database, which contains 495,729 SNPs of 32,108 human lncRNA transcripts from 17,436 lncRNA genes (human GRCh37) (Gong, Liu, Zhang, Miao, & Guo, 2015) . The database also provided synthetic and integrated information about lncRNA SNPs and their potential functions and interrelation with other loci (Gong et al., 2015) . When comparing the genotyped SNPs in our GWAS samples with SNPs from LncRNASNP-human database, 55,906 lncRNA SNPs were shared and selected in the subsequent analysis.
GWAS meta-analysis
For each GWAS study, BMD measurements were adjusted by significant covariates: sex, age, weight, height, scan side (in FHS), and scanner ID (in WHI-AA and WHI-HIS) by a stepwise linear regression model, and principal component analysis was computed to correct for potential population stratification . For each unrelated subjects, association was computed by the linear regression statistical model using MACH2QTL (Li, Willer, Ding, Scheet, & Abecasis, 2010) , and allele dosage was used as a phenotype prognosticator. In total, 5,842,825 SNPs were qualified in the meta-analyses, and overall genomic control inflation factors for three BMD traits ranged from 0.99 to 1.04 .
METAL (https://www.sph.umich.edu/csg/abecasis/metal/) were used to implement weighted fixed-effect meta-analysis, and Cochrane's Q statistic and I 2 were calculated as measures of between-study heterogeneity (Tan et al., 2014; . Random-effect meta-analyses were performed for SNPs with a Q statistic P-value < 0.05 or I 2 > 50% (Tan et al., 2014) . Forest plots were performed to present the effect size of identified candidate SNPs in metaanalysis, and odds ratios (ORs) and their 95% confidence intervals (95% CI) were calculated using Review Manager (https://ims.cochrane.org/revman) (Tan et al., 2014) .
To constrain the probability of false positives, Bonferroni correction was applied for multiple tests. P = 8.94 × 10 −7 (i.e., 0.05/55906) was applied to as a genome-wide significant criterion, while P = 1.00 × 10 −4 was regarded as suggestively significant level.
LncRNA secondary structures prediction
The structural features of lncRNAs play important roles, by acting as a scaffold, and a portion of lncRNAs can exert their functions by scaffolding protein complexes (Gong et al., 2015; Zhu, Fu, Wu, & Zheng, 2013) . SNPs located in lncRNA may affect the lncRNA secondary structure, stability, expression, and functions (Gong et al., 2015; Nagano & Fraser, 2011) . To access the influence of polymorphism alleles on lncRNAs' secondary structure, the RNAfold online tool (https://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi) was applied to illustrate the change of secondary structure and calculate the Minimum Free Energy (MFE) (Gruber, Lorenz, Bernhart, Neubock, & Hofacker, 2008 ).
miRNA-lncRNA interactions prediction
LncRNAs SNPs in the miRNA target sites may create or break miRNA binding sites, and polymorphisms would lead to change of miRNA-lncRNA interactions (Gong et al., 2015) . SNPs impact of miRNA-lncRNA interactions was predicted from lncRNASNP database (Gong et al., 2015) . The lncR-NASNP database applied miRanda and TargetScan to predict potential miRNA target sites around lncRNA SNPs (±25 bp around SNP) (Gong et al., 2015) .
RESULTS
The main characteristics of samples were summarized in Table 1 . Chinese and Hispanic BMD were relatively lower than that of Caucasians and African Americans.
We identified two significant loci in our GWAS metaanalysis. MEF2C antisense RNA 1 (MEF2C-AS1) located at 5q14.3 was significantly associated with femoral neck BMD (FN-BMD), of which the strongest association was rs6894139 (P = 3.03 × 10 −9 ) and allele-specific OR (95% CI) ranged from 0.89 to 0.93. rs6894139 was previously reported to be associated with BMD in our earlier GWAS, but it was annotated in the MEF2C gene . Our previous study did not highlight the important role of rs6894139 in osteoporosis. LOC100506136 located at 7q21.3, of which the strongest association was rs6465531 (P = 7.43 × 10 −7 for total hip BMD (HIP-BMD)). Allelespecific OR (95% CI) ranged from 0.88 to 0.98 for HIP-BMD. Figure 1 showed the forest plot of the two identified SNPs, MEF2C-AS1 rs6894139 (T/G) for FN-BMD and LOC100506136 rs6465531 (G/A) for HIP-BMD. Additionally, 24 loci showed nominally significant associations (P < 10 −4 ). We listed results of GWAS meta-analysis associations of SNPs with BMD (with P < 10 −4 ) in Tables 2-4. To validate these findings, these 26 loci of potential interest (2 significant and 24 nominally significant SNPs) were replicated in GEFOS Sequencing dataset encompassing 32,965 individuals with BMD at femoral neck and lumbar spine. MEF2C-AS1 rs6894139 were significantly associated with FN-BMD (P = 1.43 × 10 −23 ), which was not reported in earlier GEFOS Sequencing (Estrada et al., 2012; Rivadeneira et al., 2009) . Of the nominally significant SNPs, LOC100506136 rs10242216 (P = 9.80 × 10 −5 ) was significantly associated with FN-BMD in the GEFOS Sequencing dataset. LOC105369209 rs1572095 (P = 2.87 × 10 −5 ) and rs1572094 (P = 3.55 × 10 −5 ), rs3761226 (P = 8.98 × 10 −5 ) and BDNF-AS rs1808124 (P = 5.11 × 10 −4 ) was significantly associated with Legend: SNP: single nucleotide polymorphisms; FN: femoral neck BMD; MAF: minor allele frequency; weight: the sum of the individual study weights for this marker; Z-score: the combined z-statistic for this marker, is the ratio of effect size estimate and standard error, for each allele are combined across of studies in an inverse variance; P-value: meta-analysis P-value; Direction: summary of effect direction for each study, with one "+" or "-" per study; I 2 : heterogeneity measure. Bold SNPs was P-value < 10 −4 in GEFOS Sequencing dataset.
lumbar spine BMD (SPN-BMD) in the GEFOS Sequencing dataset. RNAfold predicted that rs6894139 might change the secondary structure and MFE of MEF2C-AS1. Figure 2 shows that the secondary structure of MEF2C-AS1 transcript (NR_109941.1) carried rs6894139-T allele or rs6894139-G allele, respectively. The optimal secondary structures for these two forms had different MFEs (-191.20 kcal/mol for rs6894139-T allele and -193.90 kcal/mol for rs6894139-G allele), and the latter structure becomes more stable. They also have different MFE structure, encoding base-pair probabilities and folding patterns in the middle of the secondary structures, as it was pointed out by the arrow in the diagram. Since the conformation of the rs6894139-T allele with a higher MFE (ΔMFE = 2.7 kcal/mol) differs from that of the rs6894139-G allele, the MEF2C-AS1 rs6894139 could potentially affect lncRNA function.
We also predicted miRNA target sites around the lncSNPs region. We found that a G > T change at rs6894139 may destroy the binding sites of hsa-miR-369-3p and hsamiR-8084 on lncRNA MEF2C-AS1, which may cause loss of function of miRNA-lncRNA interactions. A G > A change at rs6465531 may give rise to gain function and develop the binding sites of hsa-miR-4302 and hsa-miR199a-5p on lncRNA LOC100506136. The miRNA may regulate the transcription of lncRNA; therefore, the destruction of miRNA-lncRNA interaction may cause allelic-specific lncRNA expression. Legend: SNP: single nucleotide polymorphisms; HIP: total hip BMD; MAF: minor allele frequency; Weight: the sum of the individual study weights for this marker; Z-score: the combined z-statistic for this marker, it is the ratio of effect size estimate and standard error, for each allele are combined across of studies in an inverse variance; P-value: meta-analysis P-value; Direction: summary of effect direction for each study, with one "+" or "-" per study; I 2 : heterogeneity measure.
T A B L E 3 Results of GWAS meta-analysis associations of lncSNPs with HIP-BMD (with P-value
DISCUSSION
In the present study, we explored the important roles of lncRNAs polymorphism in determining variations of BMD for the first time. We found that MEF2C-AS1 rs6894139 was associated with FN-BMD and LOC100506136 rs6465531 was associated with HIP-BMD. The intergenic polymorphism rs6894139 can influence the MEF2C-AS1 transcript secondary structure by changing the folding pattern and MFEs and thus may potentially affect the function of MEF2C-AS1, such as signal, decoy, guide, or scaffold proteins and transcriptional regulation of gene expression. SNP rs6894139 in the miRNA target sites may destroy hsa-miR-369-3p and hsa-miR-8084 binding sites on MEF2C-AS1 with a G > T alteration and may cause loss of function of miRNA-lncRNA interactions. Therefore, SNP rs6894139 may potentially influence the expression of MEF2C-AS1.
A previous study showed that a mouse BMD quantitative trait locus was mapped in MEF2C-AS1 region (AckertBicknell et al., 2010) . Mo et al. (2015) showed that MEF2C-AS1 was associated with FN-BMD (P = 3.72 × 10 −8 ) using gene-based analysis with GEFOS-2 data. Hence, MEF2C-AS1 is an important locus in determining BMD variation.
Antisense RNA transcription is initiated in the opposite strand either within the gene body or at the end of its sense transcript (Katayama et al., 2005) . Relative to sense genes, antisense genes are transcribed head-to-head, tail-to-tail, or fully overlapping (Katayama et al., 2005) . Antisense genes can interact with sense genes. For example, antisense gene AS-RBM15 enhanced its sense gene, and RBM15 protein translation in a head-to-head overlapping in the 5 ′ UTR (Tran et al., 2016) . Antisense gene FGFR3-AS1 through pairing with FGFR3 in tail-to-tail overlapping in the 3 ′ UTR, increased FGFR3 mRNA stability and upregulated FGFR3 expression (Sun et al., 2016) . In our study, the antisense MEF2C-AS1 transcript overlapped with the 5 ′ UTR of MEF2C, and we speculate that lncRNA MEF2C-AS1 may play a role in MEF2C expression and/or translation (Chen, Sun, Hurst, Carmichael, & Rowley, 2005; Tran et al., 2016) . A functional study showed that expression of a dominant-negative MEF2C mutant or T A B L E 4 Results of GWAS meta-analysis associations of lncSNPs with SPN-BMD (with P-value < 10 −4 ) genetic deletion of MEF2C impaired cartilage angiogenesis, ossification, and longitudinal bone growth, on the contrary, superactivated MEF2C caused precocious chondrocyte hypertrophy, ossification of growth plates, and dwarfism (Arnold et al., 2007) . We assume that lncRNA MEF2C-AS1 through affecting MEF2C expression and/or translation may indirectly influence the endochondral bone development. However, the hypotheses need further functional studies. SNP rs6465531 is located in the intron region of NR_038948.1 (uncharacterized LOC100506136). A G > A alteration of SNP rs6465531 may create the binding sites of hsa-miR-4302 and hsa-miR-199a-5p on lncRNA. Previous studies revealed that hsa-miR-199a-5p regulated osteogenic differentiation of human MSCs at early and late stages via the HIF1a pathway, and miR-199a-5p overexpression could improve the in vivo regeneration of bone . These findings imply the potential role of LOC100506136 rs6465531 in bone metabolism.
There are some limitations in the present study. First, four samples overlapped between our discovery study and GEFOS Sequencing sample. Because GEFOS Sequencing data did not provide detailed results of single sample subset, we cannot exclude the four dbGAP samples from the replication sample. Besides, small sample size and imbalanced sex ratio may lead to limited statistical power. However, our findings can provide new insights on the lncSNP role in determining BMD variation.
In summary, in our present study, we have identified two lncRNAs polymorphisms associated with BMD. Although we have no specifically experimental proof to figure out the biologic mechanisms underlying the GWAS association, our results enhance the information and awareness of the associations between lncRNAs polymorphisms and BMD, and they supply a clue for succeeding functional studies of these relevant lncSNPs in osteoporosis pathophysiology.
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